For millions of cancer patients worldwide, the life-saving potential of chemotherapy is frequently tempered by a debilitating side effect known…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of modern drug development is currently undergoing a radical structural shift, characterized by an unprecedented explosion in the…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has undergone a radical transformation over the last decade, yet the public health…
Read More
After decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice
For millions of cancer patients worldwide, the life-saving potential of chemotherapy is frequently tempered by a debilitating, long-term side effect:…
Read More
Sling Therapeutics Secures $123M in Series C Financing to Advance Pivotal Phase III Trial of First-in-Class Oral TED Treatment
Sling Therapeutics has closed a significant $123 million Series C financing round, directing the capital toward the pivotal late-stage clinical…
Read More
As the dream of the autonomous clinical trial dawns, agent supervision is today’s human job
The landscape of clinical research is undergoing a seismic shift, characterized by a staggering escalation in data volume and the…
Read More
AbbVie’s Maviret cured 96% of HCV trial participants. The real world is more complicated.
The landscape of hepatitis C (HCV) management has shifted significantly with the recent regulatory approvals of AbbVie’s direct-acting antiviral therapy,…
Read More
After decades of trial failures in chemotherapy-linked neuropathy, psilocybin shows promise in preventing it in mice
The search for an effective prophylactic against Chemotherapy-Induced Peripheral Neuropathy (CIPN) has been one of the most frustrating chapters in…
Read More
ADA Conference Marked by Landmark GLP-1 Trial Results Amidst Unprecedented Scientific Dissent and Police Intervention
The annual national conference of the American Diabetes Association (ADA) this week served as a dual stage: a vibrant forum…
Read More
Remepy’s Hybridopa, a Pioneer in AI-Driven Hybrid Drugs, Demonstrates Significant Efficacy in Parkinson’s Phase IIa Trial
San Francisco, CA – May 2026 – Remepy, a burgeoning health technology startup at the vanguard of integrating pharmaceutical and…
Read More
